Concourse Financial Group Securities’s Larimar Therapeutics LRMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 4782 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 5799 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 5790 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 5816 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 5822 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 5761 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 5645 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 5524 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 5331 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 5323 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 5139 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 5148 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 5052 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 5076 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 4949 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 4793 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 4661 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 4538 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 4353 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 4235 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 4229 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 4179 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 3953 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 4171 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 4109 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 3989 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 3683 |
|